Tao Lin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation (NCT06453135) | Tao Lin | 2024-07-01 |
Track Tao Lin automatically
Every clearance here is in the API, with alerts when new ones post.